RG
GMAB icon

Redmile Group’s Genmab GMAB Stock Holding History

Redmile Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-661,621
Closed -$26.2M – 71
2021
Q4 		$26.2M Sell
661,621
-458,767
-41% -$19.1M 0.6% 41
2021
Q3 		$49M Sell
1,120,388
-107,200
-9% -$4.81M 0.85% 38
2021
Q2 		$50.1M Sell
1,227,588
-104,624
-8% -$4.04M 0.74% 40
2021
Q1 		$43.7M Buy
+1,332,212
New +$50.1M 0.62% 50
2020
Q3 		– Sell
-1,057,393
Closed -$35.8M – 85
2020
Q2 		$35.8M Sell
1,057,393
-491,607
-32% -$13.4M 0.66% 44
2020
Q1 		$32.8M Buy
1,549,000
+612,300
+65% +$13.6M 0.92% 35
2019
Q4 		$20.9M Sell
936,700
-311,900
-25% -$6.81M 0.5% 49
2019
Q3 		$25.3M Buy
+1,248,600
New +$24.6M 0.85% 39

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group's GMAB Position: Q1 2022 in Review

Redmile Group sold out of Genmab (GMAB) in Q1 2022, closing a stake of 661,621 shares — an estimated $26.2M sold.

Redmile Group first reported a position in GMAB in Q3 2019 and held it in 8 quarters. The position peaked at $50.1M in Q2 2021. 204 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

  • Redmile Group reported no remaining Genmab position as of Q1 2022 after selling out during the quarter.
  • Redmile Group sold 661,621 Genmab shares in Q1 2022, an estimated $26.2M.
  • Redmile Group first reported a position in Genmab in Q3 2019 and held it in 8 quarters.
  • Redmile Group's Genmab position peaked at $50.1M in Q2 2021.
  • 204 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Redmile Group's 13F filing for Q1 2022, filed 16 May 2022.